We invite you to watch our new video presenting the main advantages of the IntelliseqFlow platform!

Intelliseq has been partnering with Boehringer Ingelheim Pharma GmbH & Co KG on a project dedicated to central nervous system diseases.  The long-range goal of

Intelliseq has accomplished the Founders Academy: Business Model Mastering – an in-depth program for companies to validate their value offer and profit-making plan. It is

We are thrilled to announce the release of IntelliseqFlow, an automated and cost-effective web-based platform for NGS data analysis! IntelliseqFlow translates raw DNA data into complete reports

Variant classification is crucial for the clinical interpretation of findings in patients’ genetic makeup. Intelliseq’s reports include ACMG/AMP recommendations and a score indicating each variant

How did Intelliseq start? What capabilities does IntelliseqFlow platform bring into the lab? How do we envision the future of our industry? Read our new

Well-designed reports showing DNA test results facilitate the work of genetic consultants and help customers understand the test result. How did we approach such a

The vast majority of differences between humans is caused by variations in their DNA, usually by alterations within a single nucleotide (SNP – single nucleotide

Pharmacogenomics, according to the National Library of Medicine, is the study of how genes affect a person’s response to drugs. This relatively new field combines